HeartSciences (HSCS) Profit After Tax (2021 - 2026)

HeartSciences (HSCS) has reported Profit After Tax for 6 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• Quarterly Profit After Tax fell 31.35% year-over-year to -$2.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$9.3 million (down 5.54% YoY) and the FY2026 annual result came in at -$9.1 million, down 4.3% from the prior year.
• Profit After Tax eased to -$2.8 million in Q2 2026 per HSCS's latest filing, from -$2.4 million in the prior quarter.
• Over the last five years, Profit After Tax for HSCS reached as high as -$1.2 million in Q1 2022 and fell as low as -$2.8 million in Q2 2026.
• A 5-year average of -$1.9 million and a median of -$1.8 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax tumbled 213.5% — and 2023, when it rose 20.49%.
• Year by year, Profit After Tax stood at -$1.8 million in 2022, then climbed by 3.22% to -$1.7 million in 2023, then decreased by 19.13% to -$2.1 million in 2024, then decreased by 12.86% to -$2.4 million in 2025, then slipped by 17.02% to -$2.8 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$2.8 million, -$2.4 million, and -$2.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.